[D-Ala2,D-Leu5]-enkephalin (DADLE) and morphine-induced postconditioning by inhibition of mitochondrial permeability transition pore, in human myocardium

Experimental Biology and Medicine

Volumn 238, Issue 4, 2013, Pages 426-432

  Fuardo, Marinella ^a,b   Lemoine, Sandrine ^c   Lo Coco, Claudia ^b   Hanouz, Jean Luc ^c,d   Massetti, Massimo ^d  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c France   (France)

^d CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

DADLE; Hypoxia reoxygenation injury; Morphine; mPTP; Postconditioning

Indexed keywords

ATRACTYLOSIDE; ENKEPHALIN [2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; MORPHINE; UNCLASSIFIED DRUG;

AORTA VALVE REPLACEMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HEART MUSCLE; HUMAN; HUMAN TISSUE; HYPOXIA; MITOCHONDRIAL PERMEABILITY; REOXYGENATION;

EID: 84880466638     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370212474602     Document Type: Article

References (34)

1. Valtchanova-Matchouganska A, Ojewole JAO. Mechanisms of opioid delta and kappa receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction. Cardiovasc J South Africa 2003;14:73-80
2. Genade S, Moolman JA, Lochner A. Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. Cardiovasc J S Afr 2001;12:8-16
3. Kim JM, Jang YH, Kim J. Morphine and remifentanil-induced cardioprotection: its experimental and clinical outcomes. Korean J Anesthesiol 2011;61:358-66
4. Karck M, Tanaka S, Bolling S, Simon A, Tsung-Ping S, Oeltgen P, Haverich A. Myocardial protection by ischemic preconditioning and delta-opioid receptor activation in the isolated working rat heart. J Thorac Cardiovasc Surg 2001;122:986-92
5. Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Postconditioning prevents reperfusion injury by activating d-opioid receptors. Anesthesiology 2008;108:243-50
6. Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 2008;294:H1444-51
7. Kim JH, Chun KJ, Park YH, Kim J, Kim JS, Jang YH, Lee MY, Park JH. Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via delta-1 opioid receptors activation in isolated rat hearts. Korean J Anesthesiol 2011;61:69-74
8. Min TJ, Kim JI, Kim JH, Noh KH, Kim TW, Kim WY, Lee YS, Park YC. Morphine postconditioning attenuates ICAM-1 expression on endothelial cells. J Korean Med Sci 2011;26:290-6
9. Weihrauch D, Krolikowski JG, Bienengraeber M, Kersten J, Warltier DC, Pagel PS. Morphine enhances Isoflurane-induced postconditioning against myocardial infarction: the role of phosphatidylinositol-3-kinase and opioid receptors in rabbits. Anesth Analg 2005;101:942-9
10. Peart JN, Gross ER, Reichelt ME, Hsu A, Headrick JP, Gross GJ. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol 2008;103:454-63
11. You L, Li L, Xu Q, Ren J, Zhang F. Postconditioning reduces infarct size and cardiac myocyte apoptosis via the opioid receptor and JAK-STAT signaling pathway. Mol Biol Rep 2011;38:437-43
12. Gross ER, Hsu AK, Gross GJ. GSK3 beta inhibition and K (ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol 2007;102:341-9
13. Chen Z, Li T, Zhang B. Morphine postconditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res 2007;145:287-94
14. Vecchio L, Soldani C, Bottone MG, Malatesta M, Martin TE, Rothblum LI, Pellicciari C, Biggiogera M. DADLE induces a reversible hibernation-like state in HeLa cells. Histochem Cell Biol 2006;125:193-201
15. Chien SF, Oeltgen PR, Diana JN, Salley RK, Su TP. Extension of tissue survival time in multiorgan block preparation using a delta opioid DADLE. J Thorac Cardiovasc Surg 1994;107:964-7
16. Bell S, Sack M, Patel A, Opie L, Yellon DM. Delta Opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 2000;36:2296-302
17. Hausenloy DJ, Ong SB, Yellon DM. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 2009;104:189-202
18. Halestrap A, Clarke S, Javadov S. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res 2004;61:372-85
19. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005;111:194-7
20. Shanmuganathan S, Hausenloy D, Duchen M, Yellon D. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 2005;289:H237-42
21. Lemoine S, Zhu L, Beauchef G, Lepage O, Babatasi G, Ivascau C, Massetti M, Galera P, Gerard JL, Hanouz JL. Role of 70-kDa ribosomal protein S6 kinase, nitric oxide synthase, glycogen synthase kinase-3b, and mithochondrial permeability transition pore in desflurane-induced postconditioning in isolated human right atria. Anesthesiology 2010;112:1355-63
22. Paradise NF, Schmitter JL, Surmitis JM. Criteria for adequate oxygenation of isometric kitten papillary muscle. Am J Physiol 1981;241:H348-53
23. Dershwitz M, Walsh J, Morishige R, Connors P, Rubsamen R, Shafer S, Rosow C. Pharmacokinetics and Pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers. Anesthesiology 2000;93:619-28
24. Corli O. Continuing Education in Algologia. Roma: Il Pensiero Scientifico Editore, 2001
25. 5] enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat. J Surg Res 2003;114:72-7
26. 5] enkephalin in neuronal death and retarded behaviour induced by forebrain ischemia in rats. Neurosci Lett 2007;423:113-7
27. Gao C, Li J-P, Wang W, Lu B-C, Niu L, Zhu C, Wei Y, Zhang T, Wu S, Chai W, Li Y. Effects of intracerebroventricular application of the delta opioid receptor agonist (d-Ala2, d-Leu5) enkephalin on neurological recovery following asphyxial cardiac arrest in rats. Neuroscience 2010;168:531-42
28. Yang JZ, Chen W, Borchardt RT. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs. J Pharmacol Exp Ther 2002;303:840-8
29. Forster K, Kuno A, Solenkova N, Felix S, Krieg T. The δ-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival Kinases via EGF receptor transactivation. Am J Physiol Heart Circ Physiol 2007;293:H1604-8
30. Wong GTC, Li R, Jiang LL, Irwin MG. Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand 2010;54:510-8
31. Lemoine S, Zhu L, Massetti M, Gérard JL, Hanouz JL. Continuous administration of remifentanil and sufentanil induces cardioprotection in human myocardium, in vitro. Acta Anaesthesiol Scand 2011;55:758-64
32. Bruel C, Parienti JJ, Marie W, Arrot X, Daubin C, Cheyron DD, Massetti M, Charbonneau P. Mild hypothermia during advanced life support: a preliminary study in out-of-hospital cardiac arrest. Critical Care 2008;12:R31
33. Gateau-Roesch O, Argaud L, Ovize M. Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 2006;70:264-73
34. Wang S, Duan Y, Su D, Li W, Tan J, Yang D, Wang W, Zhao Z, Wang X. Delta opioid peptide [d-Ala2,d-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia. Eur J Pharmacol 2011;658:140-4